Literature DB >> 24352326

NF-κB control of T cell development.

Steve Gerondakis1, Thomas S Fulford1, Nicole L Messina1, Raelene J Grumont1.   

Abstract

The NF-κB signal transduction pathway is best known as a major regulator of innate and adaptive immune responses, yet there is a growing appreciation of its importance in immune cell development, particularly of T lineage cells. In this Review, we discuss how the temporal regulation of NF-κB controls the stepwise differentiation and antigen-dependent selection of conventional and specialized subsets of T cells in response to T cell receptor and costimulatory, cytokine and growth factor signals.

Mesh:

Substances:

Year:  2014        PMID: 24352326     DOI: 10.1038/ni.2785

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  106 in total

1.  The NF-κB transcription factor c-Rel is required for Th17 effector cell development in experimental autoimmune encephalomyelitis.

Authors:  Guobing Chen; Kristine Hardy; Eloisa Pagler; Lina Ma; Seungsoo Lee; Steve Gerondakis; Stephen Daley; M Frances Shannon
Journal:  J Immunol       Date:  2011-09-21       Impact factor: 5.422

Review 2.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

Review 3.  Transcriptional regulation via the NF-kappaB signaling module.

Authors:  A Hoffmann; G Natoli; G Ghosh
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

Review 4.  Raising the NKT cell family.

Authors:  Dale I Godfrey; Sanda Stankovic; Alan G Baxter
Journal:  Nat Immunol       Date:  2010-02-07       Impact factor: 25.606

Review 5.  Transcriptional drivers of the T-cell lineage program.

Authors:  Ellen V Rothenberg
Journal:  Curr Opin Immunol       Date:  2012-01-19       Impact factor: 7.486

6.  Premature TCR alpha beta expression and signaling in early thymocytes impair thymocyte expansion and partially block their development.

Authors:  H D Lacorazza; C Tucek-Szabo; L V Vasović; K Remus; J Nikolich-Zugich
Journal:  J Immunol       Date:  2001-03-01       Impact factor: 5.422

7.  Mature T cells depend on signaling through the IKK complex.

Authors:  Marc Schmidt-Supprian; Gilles Courtois; Jane Tian; Anthony J Coyle; Alain Israël; Klaus Rajewsky; Manolis Pasparakis
Journal:  Immunity       Date:  2003-09       Impact factor: 31.745

Review 8.  Checkpoints in lymphocyte development and autoimmune disease.

Authors:  Harald von Boehmer; Fritz Melchers
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

9.  The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator.

Authors:  Yu Hikosaka; Takeshi Nitta; Izumi Ohigashi; Kouta Yano; Naozumi Ishimaru; Yoshio Hayashi; Mitsuru Matsumoto; Koichi Matsuo; Josef M Penninger; Hiroshi Takayanagi; Yoshifumi Yokota; Hisakata Yamada; Yasunobu Yoshikai; Jun-Ichiro Inoue; Taishin Akiyama; Yousuke Takahama
Journal:  Immunity       Date:  2008-09-19       Impact factor: 31.745

10.  T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse.

Authors:  Amy E Moran; Keli L Holzapfel; Yan Xing; Nicole R Cunningham; Jonathan S Maltzman; Jennifer Punt; Kristin A Hogquist
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

View more
  91 in total

Review 1.  Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events.

Authors:  Shenq-Shyang Huang; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-08

2.  The 135 Gene of Goatpox Virus Encodes an Inhibitor of NF-κB and Apoptosis and May Serve as an Improved Insertion Site To Generate Vectored Live Vaccine.

Authors:  Minmin Zhang; Yirui Sun; Weiye Chen; Zhigao Bu
Journal:  J Virol       Date:  2018-08-29       Impact factor: 5.103

Review 3.  Transcription factors and target genes of pre-TCR signaling.

Authors:  Cristina López-Rodríguez; Jose Aramburu; Rosa Berga-Bolaños
Journal:  Cell Mol Life Sci       Date:  2015-02-22       Impact factor: 9.261

Review 4.  Long non-coding RNA: a versatile regulator of the nuclear factor-κB signalling circuit.

Authors:  Xiaohua Mao; Zhenyi Su; Adnan K Mookhtiar
Journal:  Immunology       Date:  2017-01-19       Impact factor: 7.397

5.  The Activation of NF-κB in Infiltrated Mononuclear Cells Negatively Correlates with Treg Cell Frequency in Oral Lichen Planus.

Authors:  Dunfang Zhang; Jiayi Wang; Zhangwei Li; Min Zhou; Qianming Chen; Xin Zeng; Yu Chen
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

6.  Selective Lesioning of Nuclear Factor-κB Activated Cells in the Nucleus Accumbens Shell Attenuates Alcohol Place Preference.

Authors:  S E Nennig; H D Fulenwider; S H Chimberoff; B M Smith; J E Eskew; M K Sequeira; C Karlsson; C Liang; J F Chen; M Heilig; J R Schank
Journal:  Neuropsychopharmacology       Date:  2017-09-13       Impact factor: 7.853

7.  Inhibition of KPNA4 attenuates prostate cancer metastasis.

Authors:  J Yang; C Lu; J Wei; Y Guo; W Liu; L Luo; G Fisch; X Li
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

8.  Inhibitor of NFκB Kinase Subunit 2 Blockade Hinders the Initiation but Aggravates the Progression of Crescentic GN.

Authors:  Janine Gotot; Eveline Piotrowski; Martin S Otte; André P Tittel; Guo Linlin; Chen Yao; Karl Ziegelbauer; Ulf Panzer; Natalio Garbi; Christian Kurts; Friedrich Thaiss
Journal:  J Am Soc Nephrol       Date:  2015-11-16       Impact factor: 10.121

Review 9.  NF-κB, inflammation, immunity and cancer: coming of age.

Authors:  Koji Taniguchi; Michael Karin
Journal:  Nat Rev Immunol       Date:  2018-01-22       Impact factor: 53.106

Review 10.  Integrating canonical and metabolic signalling programmes in the regulation of T cell responses.

Authors:  Kristen N Pollizzi; Jonathan D Powell
Journal:  Nat Rev Immunol       Date:  2014-07       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.